Regarding clinical outcomes, 30-day mortality showed a decreased tendency for the dRAST group ( n = 19 vs 13), although the sample size is small and it did not reach statistical significance.
← all excerpts
Randomized controlled diagnostic trial to assess dRAST time to result and its utility for antimicrobial stewardship recommendation in bacteremic patients.
1
—
—